India Inc seems to have weathered the demonetisation storm, as most companies have reported better than expected profit numbers in the quarter... ...http://www.mydigitalfc.com/news/resilience-display-369
Sun Pharmaceutical, which is growing its dermatology and ophthalmic specialty business in the US will spend $460 million on R&D. Indian pharma... ...http://www.rediff.com/money/report/big-pharmas-mega-plan-to-beat-competition-in-us/20170220.htm
Posted by Equitymaster Asian stock markets are trading mixed in morning trade. The Nikkei 225 is down 0.14%, while the Hang Seng and the Shanghai... ...http://feeds.equitymaster.com/~r/TodaysMarket/~3/67VZ4JGDKGc/tm.asp
'The big elephant in the room is our misguided view about the rupee.''India is scared that if our currency appreciates, who will buy from us. But a... ...http://www.rediff.com/money/interview/ive-been-crying-about-the-decline-in-the-rupee/20170216.htm
Auto, realty and pharma counters took a big hit ...http://www.business-standard.com/article/specials/sensex-tanks-184-pts-on-earnings-fed-117021501427_1.html
New SAS Training Batch starts very...
PHARMA PROVA was established on 1971...
Sacred is a young...